(Q43992514)

28 November 2017

title

Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers (English)

1 reference

28 November 2017

main subject

Clostridium difficile

0 references

author

Spencer E. Harpe

3

1 reference

28 November 2017

Amy Pakyz

1

1 reference

28 November 2017

Norman V Carroll

2

1 reference

28 November 2017

Michael Oinonen

4

1 reference

28 November 2017

Ronald E Polk

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2011

1 reference

28 November 2017

1 reference

28 November 2017

volume

31

1 reference

28 November 2017

issue

6

1 reference

28 November 2017

page(s)

546-551

1 reference

Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

Increased Clostridium difficile virulence demands new treatment approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

Review of current literature on the economic burden of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

Trends in antibacterial use in US academic health centers: 2002 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

Methods for improving regression analysis for skewed continuous or counted responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

Economic healthcare costs of Clostridium difficile infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.6.546

21 January 2018

Identifiers

DOI

10.1592/PHCO.31.6.546

1 reference

release_maimkbqjozcctgtp5bf3txhqmy

28 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/maimkbqjozcctgtp5bf3txhqmy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference